"This Pharmasset effort is drawing even more attention because it potentially eliminates the need for patients to be treated with long-acting interferon, one of two drugs currently used to treat hepatitis C but which is difficult for patients to tolerate and causes many side effects."
Wouldn't that eliminate the need for bavi? (for HEP C)
News 
Market Data 
Discover 
AI
